scholarly article | Q13442814 |
P50 | author | Timothy Billiar | Q30223707 |
Melanie J Scott | Q88123529 | ||
Jay K Kolls | Q88683872 | ||
Nataša Obermajer | Q89896742 | ||
Shabaana A Khader | Q90212547 | ||
Kunle Odunsi | Q38296739 | ||
P2093 | author name string | Jeffrey L Wong | |
Kong Chen | |||
Robert P Edwards | |||
Pawel Kalinski | |||
P2860 | cites work | Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells | Q24296669 |
Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2 | Q24299661 | ||
Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes | Q24309040 | ||
Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling | Q24625230 | ||
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses | Q24630221 | ||
T helper 17 cells promote cytotoxic T cell activation in tumor immunity | Q24646584 | ||
Tumor-specific Th17-polarized cells eradicate large established melanoma | Q24648032 | ||
Inflammation and cancer | Q24649640 | ||
IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells | Q24652221 | ||
Neutralizing tumor-promoting chronic inflammation: a magic bullet? | Q26830931 | ||
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
Cancer-related inflammation | Q27860907 | ||
Immunity, Inflammation, and Cancer | Q27861048 | ||
Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
IL-23 promotes tumour incidence and growth | Q28239522 | ||
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies | Q28283086 | ||
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells | Q28296956 | ||
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function | Q28510096 | ||
Regulation of immune responses by L-arginine metabolism | Q29614284 | ||
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways | Q29614839 | ||
Development, cytokine profile and function of human interleukin 17-producing helper T cells | Q29617131 | ||
Nitric oxide and the immune response | Q29617591 | ||
Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells | Q29618163 | ||
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells | Q29622847 | ||
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells | Q33335471 | ||
Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases | Q33584105 | ||
Myelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide | Q33793585 | ||
T Cell Activation-Induced Mitochondrial Hyperpolarization Is Mediated by Ca2+- and Redox-Dependent Production of Nitric Oxide | Q33834238 | ||
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes | Q33978763 | ||
NO news is good news | Q34245390 | ||
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. | Q34287902 | ||
Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells | Q34333949 | ||
Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP | Q34415795 | ||
Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. | Q34828944 | ||
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer | Q34843832 | ||
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments | Q34983123 | ||
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway | Q34989745 | ||
Regulation of type 17 helper T-cell function by nitric oxide during inflammation | Q35021942 | ||
Nitric oxide modulates TGF-beta-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development | Q35041388 | ||
Radical causes of cancer. | Q35097371 | ||
L-arginine metabolism in myeloid cells controls T-lymphocyte functions. | Q35155944 | ||
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. | Q35553327 | ||
Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy | Q35599161 | ||
Interleukin-17 promotes angiogenesis and tumor growth | Q78460523 | ||
Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses | Q81455935 | ||
Regulation of lymphocytes by nitric oxide | Q85185795 | ||
T(H)17 cells in tumour immunity and immunotherapy. | Q35623903 | ||
Inducible nitric oxide synthase activation by interleukin-17. | Q35640431 | ||
Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis | Q36049347 | ||
Suppression of arthritis by an inhibitor of nitric oxide synthase | Q36362115 | ||
The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orall | Q36362801 | ||
IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination | Q36375426 | ||
Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis | Q36463855 | ||
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth | Q36696555 | ||
T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 | ||
Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion | Q36948594 | ||
IL-23 promotes maintenance but not commitment to the Th17 lineage | Q37183888 | ||
Critical regulation of early Th17 cell differentiation by interleukin-1 signaling | Q37250727 | ||
Type 17 CD8+ T cells display enhanced antitumor immunity. | Q37268980 | ||
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans | Q37363065 | ||
The IL-17/IL-23 axis of inflammation in cancer: friend or foe? | Q37513880 | ||
Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter | Q37729096 | ||
Myeloid-Derived Suppressor Cells in Human Cancer | Q37778697 | ||
Deciphering the role of Th17 cells in human disease | Q37940695 | ||
The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy | Q38039112 | ||
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. | Q39770285 | ||
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 | ||
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. | Q40758963 | ||
Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling | Q41330743 | ||
Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer | Q42183073 | ||
The multiplex function of nitric oxide in (auto)immunity | Q42971599 | ||
Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes | Q43864237 | ||
Nitric oxide-mediated inhibition of caspase-dependent T lymphocyte proliferation | Q44569270 | ||
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion | Q46440292 | ||
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. | Q47883923 | ||
Macrophage biology and immunology: man is not a mouse | Q49922501 | ||
Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. | Q52014124 | ||
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host | Q57054792 | ||
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression | Q59387557 | ||
Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine | Q60311223 | ||
Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes | Q67543297 | ||
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease | Q72088538 | ||
Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells | Q73178559 | ||
Species differences in macrophage NO production are important | Q77550397 | ||
Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? | Q77723681 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1433-1445 | |
P577 | publication date | 2013-07-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling | |
P478 | volume | 210 |
Q38564348 | (Compl)Ex-Th17-Treg cell inter-relationship |
Q37264641 | Arginine cools the inflamed gut. |
Q35674805 | Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling |
Q91826260 | Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells |
Q38234941 | Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs |
Q28075992 | Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic |
Q64071947 | Gastric Cancer Stem Cells Effect on Th17/Treg Balance; A Bench to Beside Perspective |
Q39271619 | Immunobiology of Nitric Oxide and Regulation of Inducible Nitric Oxide Synthase |
Q39349334 | Immunological Functions of the Omentum |
Q35181305 | Inducible nitric oxide synthase (iNOS) regulatory region variation in non-human primates |
Q28070110 | Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend? |
Q50056000 | Measuring bovine γδ T cell function at the site of Mycobacterium bovis infection |
Q61448742 | Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation |
Q47702288 | MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells |
Q47550777 | Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections. |
Q64268432 | Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate |
Q37697695 | Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders |
Q35567331 | Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis |
Q38299932 | Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities |
Q52689050 | Myeloid-derived suppressor cells in ovarian cancer: friend or foe? |
Q33816141 | Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. |
Q28553169 | Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells |
Q35327027 | Nitric oxide sustains IL-1β expression in human dendritic cells enhancing their capacity to induce IL-17-producing T-cells |
Q40994227 | Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma |
Q26995625 | Nitric oxide synthase: non-canonical expression patterns |
Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
Q38447792 | Protein pathways working in human follicular fluid: the future for tailored IVF? |
Q38284611 | Re-thinking the functions of IgA(+) plasma cells |
Q60928063 | Regulation of iNOS on Immune Cells and Its Role in Diseases |
Q45035363 | Response to: 'Issues with anti-Gr1 antibody-mediated myeloid-derived suppressor cell depletion' by Xing et al. |
Q38136193 | Role of Th17 cells in skin inflammation of allergic contact dermatitis |
Q34486762 | Role of nitric oxide in immune responses against viruses: beyond microbicidal activity. |
Q37707927 | Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells |
Q38181087 | Th17 cells in immunity and autoimmunity. |
Q64076137 | The iNOS Activity During an Immune Response Controls the CNS Pathology in Experimental Autoimmune Encephalomyelitis |
Q36236780 | The immunogenetics of Psoriasis: A comprehensive review |
Q38957065 | The role of dendritic cells in cancer |
Q38424752 | Type 2 cytokines: mechanisms and therapeutic strategies |
Q52661681 | Update on regulation and effector functions of Th17 cells. |
Q49175582 | Upregulation of Treg-Related Genes in Addition with IL6 Showed the Significant Role for the Distant Metastasis in Colorectal Cancer. |
Q36342273 | eNOS S-nitrosylates β-actin on Cys374 and regulates PKC-θ at the immune synapse by impairing actin binding to profilin-1. |
Search more.